FeesSafety
Pluang+

Ramaco CEO Randall Atkins elected Chair of IEA's Coal Industry Advisory Board, shaping global coal policy.

Market News
03 Nov 2026, 14:30 WIB
PRNewsWire
View Source
Bullish
Ramaco CEO Randall Atkins elected Chair of IEA's Coal Industry Advisory Board, shaping global coal policy.

Randall W. Atkins, CEO of Ramaco Resources, has been unanimously elected Chair of the International Energy Agency's Coal Industry Advisory Board (CIAB). This role positions him to influence global coal, energy security, and critical minerals policy. Atkins brings over 40 years of energy sector experience and aims to advance coal's role in steelmaking, energy, and emerging technologies like rare earth extraction and advanced carbon products. His leadership also extends to the U.S. National Coal Council, reinforcing his influence on national and international energy discussions.

Randall W. Atkins's election as Chair of the International Energy Agency's Coal Industry Advisory Board is noted alongside Pluang's Energy sector market snapshot. As of Nov 03, 2026 19:01 WIB, 72 of 79 priced US Energy-sector stocks on Pluang rose while 6 fell. Notable movers include VG (Venture Global Inc. Class A) at USD 13.17 with a 1-day change of +2.33% and a typical hold time of 5 days, INDO (Indonesia Energy Corporation Limited) at USD 2.54 with a 1-day change of -2.31% and 82% sell order activity, and BTE (Baytex Energy Corp) at USD 4.90 with a 1-day change of +2.30% and a typical hold time of 11 days.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
54 minutes ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
54 minutes ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
54 minutes ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
1 hour ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App